Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Treasury to feature President Trump's signature on U.S. dollars, a historic first for a sitting president....
Former Rep. Marjorie Taylor Greene asserted that President Trump and the GOP promised "America First" but are delivering "America LAST."...
Senior South African police and a businessman have been detained over fraud and corruption linked to a controversial police contract...
